CIGNA Co. (NYSE:CI) Director Donna F. Zarcone sold 5,971 shares of the stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $215.43, for a total value of $1,286,332.53. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
CIGNA Co. (NYSE CI) opened at $220.36 on Thursday. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39. The firm has a market cap of $54,330.00, a PE ratio of 24.14, a price-to-earnings-growth ratio of 1.43 and a beta of 0.51. CIGNA Co. has a 12-month low of $133.52 and a 12-month high of $221.13.
CIGNA (NYSE:CI) last posted its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 earnings per share for the quarter, beating analysts’ consensus estimates of $2.36 by $0.47. The company had revenue of $10.38 billion during the quarter, compared to analysts’ expectations of $10.17 billion. CIGNA had a net margin of 5.74% and a return on equity of 18.85%. The firm’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.94 EPS. equities research analysts predict that CIGNA Co. will post 10.34 earnings per share for the current year.
A number of large investors have recently bought and sold shares of CI. Vanguard Group Inc. lifted its position in shares of CIGNA by 2.5% during the second quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock worth $2,867,514,000 after purchasing an additional 424,469 shares during the last quarter. FMR LLC lifted its position in shares of CIGNA by 6.7% during the second quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock worth $1,156,604,000 after purchasing an additional 432,978 shares during the last quarter. Ameriprise Financial Inc. lifted its position in shares of CIGNA by 4.8% during the third quarter. Ameriprise Financial Inc. now owns 3,776,414 shares of the health services provider’s stock worth $705,889,000 after purchasing an additional 171,712 shares during the last quarter. FIL Ltd lifted its position in shares of CIGNA by 5.2% during the second quarter. FIL Ltd now owns 2,311,938 shares of the health services provider’s stock worth $386,996,000 after purchasing an additional 113,531 shares during the last quarter. Finally, Investec Asset Management LTD lifted its position in shares of CIGNA by 35.4% during the third quarter. Investec Asset Management LTD now owns 1,849,598 shares of the health services provider’s stock worth $345,764,000 after purchasing an additional 483,904 shares during the last quarter. 87.75% of the stock is owned by institutional investors.
Several brokerages recently issued reports on CI. Royal Bank of Canada reiterated an “outperform” rating and issued a $220.00 price target (up from $185.00) on shares of CIGNA in a report on Friday, November 3rd. Credit Suisse Group began coverage on CIGNA in a report on Thursday, November 2nd. They issued an “outperform” rating and a $219.00 price target for the company. Goldman Sachs Group began coverage on CIGNA in a report on Wednesday, January 3rd. They issued a “neutral” rating and a $247.00 price target for the company. Morgan Stanley increased their price target on CIGNA from $195.00 to $223.00 and gave the company an “overweight” rating in a report on Friday, November 3rd. Finally, Jefferies Group increased their price target on CIGNA from $201.00 to $221.00 and gave the company a “buy” rating in a report on Friday, October 13th. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $205.18.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.